Dan Passeri | Chief Executive Officer |
Anish Suri | President & Chief Scientific Officer |
Matteo Levisetti | Chief Medical Officer |
Kerri Millar | Chief Financial Officer |
Ted Tenthoff | Piper Sandler |
Ren Benjamin | JMP Securities |
Greetings, and welcome to the Cue Biopharma Investor Update Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the presentation. [Operator Instructions] As a reminder, this conference is being recorded.
I would now like to turn the conference over to Dan Passeri, Cue Biopharma’s Chief Executive Officer.